• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Stocks

3 Turkey Stocks That Should Have Better Years in 2023

The prospects for this trio are better than in the current year, which has been rough on all three.
By BRET JENSEN
Nov 23, 2022 | 10:30 AM EST
Stocks quotes in this article: AMWD, OMF, AUPH

First of all, I want to wish the entire Real Money community a Happy Thanksgiving. May you have a long, relaxing and enjoyable holiday weekend spent with friends and family. While turkey is my least favorite meat, Turkey Day always has been one of my favorite holidays. I look forward to celebrating the day with copious amounts of food and good company along with a beatdown delivered by my Dallas Cowboys to our rival New York Giants this Thanksgiving.

There has been no shortage of turkeys within investors' portfolios this year as the markets have been more difficult to navigate than Lake Michigan during a squall for most of 2022. Here are a few of my turkeys that I hope can transform into game hens by the holiday next year. 

Let's start with American Woodmark (AMWD) , which has been on a nice little run of late after holding support just above $40. That said, the shares of this cabinet maker are still down 15% for the year.  The sector has been punished as interest rates have waylaid housing activity. However, American Woodmark beat both top- and bottom-line expectations when it reported third-quarter results Tuesday. While I expect the housing sector to continue to struggle until mortgage rates top out, the stock is reasonably priced at 8x earnings. The stock also happens to be a favorite of Real Money Pro columnist Paul Price.

OneMain Holdings (OMF) is another name that has started to behave better in recent weeks, although the shares are down nearly 25% so far in 2022 before accounting for the company's significant dividend payouts. Worries about credit quality have hurt this largely unsecured lender to middle- and working-class households. This is a legitimate concern as the economy looks destined to go into a recession sometime in 2023 and as the U.S. consumer has lost about 6% of their buying power to inflation since the start of 2021. That said, OneMain is well-reserved and the stock trades just above 5x earnings and yields nearly 10% at current trading levels.

Finally, we have Aurinia Pharmaceuticals (AUPH) , which has been an absolute buzzard here in 2022. This biopharma concern has lost about 75% of its value over the year. Sales of its recently approved lupus nephritis therapy Lupkynis have been under expectations and Aurinia is bleeding cash. However, slow marketing rollouts in this space are hardly a rarity.  

In addition, Lupkynis was approved in Europe late this summer. This triggered a $30 million regulatory milestone payout from Auinia's marketing partner for that region and should help boost sales going forward. Aurinia has been the target of much buyout speculation in 2022, which has been smoke to this point. However, with a market cap of about $650 million and $400 million of net cash on the balance sheet as of the end of October, this seems too logical of a buyout to not have a high probability of happening in 2023.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Jensen was long AMWD, AUPH and OMF.

TAGS: Investing | Stocks | Value Investing | Housing Market | Biotechnology | Financial Services | Pharmaceuticals | Manufacturing | Real Money | Consumer Discretionary

More from Stocks

Rule of the Week: Don't Fight the Fed

James "Rev Shark" DePorre
Jan 30, 2023 4:33 PM EST

We've got a mix of earnings, a rate decision and nervous investors.

3 High-Yield Dividend Tech Stocks for Income Investors

Bob Ciura
Jan 30, 2023 2:35 PM EST

Now could be a very good time to capitalize on sustainable income streams from a sector where dividend income is scarce.

Checking on AMD's Stock Charts Ahead of Tuesday's Earnings

Bruce Kamich
Jan 30, 2023 2:10 PM EST

Here's what to avoid for now.

Is This Mid-Cap Oil Stock Ready to Capture Its 'Big Winner' Potential?

Bruce Kamich
Jan 30, 2023 1:29 PM EST

Here's our technical strategy for trading oil producer Denbury.

Don't Fight the Fed? What About When the Fed Is Fighting Its Own Past?

Peter Tchir
Jan 30, 2023 1:00 PM EST

The biggest risk to markets in the coming weeks is the realization that the Fed has already gone far too far, and the economy is rolling over.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:27 PM EST REAL MONEY

    LIVE EVENT: Chris Versace and "Sarge" Guilfoyle Share Their Stock Market Insights

    This Monday, Jan. 30, at 12 p.m., our very own exp...
  • 11:48 AM EST REAL MONEY

    Watch Doug Kass on the Daily Rundown!

    In today's Action Alerts PLUS Daily Rundown, Doug ...
  • 11:03 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend On Real Money

    It's time to start using this power to build great...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login